Transforming HCLS and Pharma: What technology from Edge to Core to Cloud can help
Healthcare and Life Sciences (HCLS) is being profoundly transformed – perhaps more, and more quickly than any other industry. If you think you’ve seen it before, we’d argue different. The pace of change and depth of disruption is new. The size of the aging population is new. The higher cost burden on the social security system is new. The size of opportunity for precision medicine is new. The level of pressure on drug pricing is new. The potential is huge.
By reacting swiftly and using the technology in the right way, life sciences companies can become more agile, more results-driven and more focused in terms of their R&D activities and on other vital business outcomes, including:
* Precision medicine
* Cost reduction
* Faster time to market
* Easier integration and scalability
The question is not just how, but what. What technological solutions in general – and emerging technologies in particular – are coming to the rescue of organisations under cost and time pressure? How are you and should you use them, and how do you attract the right talent, to maximise competitive advantage?
Join five senior HCLS and Pharma IT executives and thought leaders for this roundtable discussion as we explore the challenges at the heart of transforming HCLS and discuss exactly what technologies, from Edge to Core to Cloud, are proven to help.
- Data analytics in clinical trials: how are you collecting, protecting, managing?
- IoT and Industry 4.0 practices in the manufacturing process: challenges and most effective solutions?
- Time to market: what technologies help shorten the development cycle of new medicines, and how?